Drugs / Leucovorin (LV)
Trials 0
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Comparator or background therapy2 trials | ||||||
| Phase 2 | NCT06684158 Background | Nov 2024 → Mar 2027 expected | gastroesophageal junction adenocarcinoma | The First Affiliated Hospital with Nanjing Medical University | Not yet recruiting | No outcome recorded |
| Phase 3 | NCT00069121 Comparator | Apr 2003 → Apr 2011 | colorectal cancer | Hoffmann-La Roche | Completed | Met primary |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Leucovorin (LV) | ClinicalTrials.gov intervention name — accepted as the source's own label NCT06684158 ↗ |
| Route | Intravenous | “LV 20 mg/m\^2 IV bolus injection” NCT00069121 ↗ |